SunSpot™ ES
(Formerly Skin Answer™)

Glycoalkaloid Gel Removes Damaged Skin Cells

SunSpot ES is a glycoalkaloid-containing skin gel that removes superficial skin lesions including pre-cancerous patches and sun spots.

Dr. Myatt’s comment
Many people have found it useful for treating skin cancer (except melanoma), although the FDA does not permit me to tell you that. 😉

Glycoalkaloids are mildly exfoliating and irritating substances found in plants. Rubbed on normal skin, they do nothing. But abnormal skin cells “take up” substances much faster than normal cells, so these abnormal cells concentrate the glycoalkaloids. Once inside the cell, the glycoalkaloids cause the breakdown and sloughing off of  the abnormal cells.

NOTE: Melanoma is a dangerous type of skin cancer and should NOT be self-tested or self-treated. Please read our page on melanoma for more information including diagnostic characteristics. Basal cell cancers and “pre-cancerous” skin lesions, usually treated by cutting, freezing or burning in conventional medicine, can also be treated with this cream. If you are unsure about what you are doing or what type of skin problem you have, please see a physician for correct diagnosis.

Recommended Use: apply a small dab of SunSpot ES to affected areas, twice daily (morning and evening). Continue until lesion has completely sloughed off.

Key Ingredients of SunSpot™ES
SunSpotES combines glycoalkaloids from sand brier with other powerful natural ingredients to exfoliate, soothe and rejuvenate skin.

Ingredients:
Water, Aloe Vera, Propylene Glycol, Salicylic Acid, Urea, Carbomer 940, Tea Tree Oil, Menthol, Glycoalkaloid Extract, Imidazolidinylurea

Precautions:
For external use only. Keep away from eyes, lips, and mucous membranes. Do not use on broken or inflamed skin. Discontinue if product causes extreme irritation. In case of accidental ingestion, contact a poison control center.

References

1. Punjabi S, Cook LJ, Kersey P, Marks R, Cerio R. Solasodine glycoalkaloids: a novel topical therapy for basal cell carcinoma. A double-blind, randomized, placebo-controlled, parallel group, multicenter study. Int J Dermatol. 2008 Jan;47(1):78-82.
2. Cham B. Solasodine Rhamnosyl Glycosides Specifically Bind Cancer Cell Receptors and Induce Apoptosis and Necrosis. Treatment for Skin Cancer and Hope for Internal Cancers. Research Journal of Biological Sciences 2 (4): 503-514, 2007.
3. Chataing, B., Christancho, N. B. and Usubillaga, A. Topical treatment of herpes simplex, herpes zoster and genital herpes with a mixture of Solanaceous glycoalkaloids. MedULA. Universidad de Los Andes. 7. 30-34, 1998.
4. Nakamura, T., Komori, C., Lee, Y., Hashinoto, F., Yahara, S., Nohara, T., and Ejina, A. Cytotoxic activities of Solanum steroidal glycosides. Biol. Biopharm. Bull. 19, 564-566, 1996.
5. Cham BE, Daunter B, Evans RA. Topical treatment of malignant and premalignant skin lesions by very low concentrations of a standard mixture (BEC) of solasodine glycosides. Cancer Lett. 1991 Sep;59(3):183-92.
6. Cham BE, Meares HM. Glycoalkaloids from Solanum sodomaeum are effective in the treatment of skin cancers in man. Cancer Lett. 1987 Aug;36(2):111-8.